ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,366Medicare Part D Prescriptions Filled, Including Refills

Rank: 161 out of 633

$491K Total Retail Price of All Prescriptions

Rank: 103 out of 633

395 Patients Receiving at Least One Drug in Part D
85% Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 395 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 397 369 64 1 1
FUROSEMIDE 363 333 57 2 6
OMEPRAZOLE 355 316 69 3 2
WARFARIN SODIUM 255 231 31 4 7
NAMENDA 231 231 22 5 34
METOPROLOL SUCCINATE 209 193 34 6 13
HYDROCODONE-ACETAMINOPHEN 208 178 68 S3 7 8
ENALAPRIL MALEATE 176 164 31 8 42
ATORVASTATIN CALCIUM 175 155 39 9 9
ESCITALOPRAM OXALATE 167 162* 25 10 40
LISINOPRIL 154 149* 29 11 5
SIMVASTATIN 139 134* 23 12 3
METOPROLOL TARTRATE 138 133* 22 13 12
POLYETHYLENE GLYCOL 3350 138 96 22 13 29
ALPRAZOLAM 131 126* 29 B 15 32
ALENDRONATE SODIUM 120 115* 22 16 35
AMLODIPINE BESYLATE 117 112* 25 17 4
CITALOPRAM HBR 113 100 23 18 20
DONEPEZIL HCL 107 107 19 19 33
MELOXICAM 107 102* 29 19 23
CYMBALTA 106 <11 <11 21 41
BYSTOLIC 106 106 17 21 55
DIOVAN 105 100* 13 23 52
ZOLPIDEM TARTRATE 105 90 27 23 26
CARVEDILOL 99 99 19 25 18
TAMSULOSIN HCL 96 91* 26 26 24
GABAPENTIN 94 77 19 27 16
FENTANYL 83 59 15 S2 28 46
ADVAIR DISKUS 83 65 19 28 51
NIASPAN 83 52 18 28 120
TRAMADOL HCL 81 76* 14 31 15
METFORMIN HCL 74 63 14 32 10
CLOPIDOGREL 74 74 18 32 30
LOSARTAN POTASSIUM 64 59* 13 34 17
AVODART 61 <11 <11 35 129
MONTELUKAST SODIUM 60 60 12 36 59
QUETIAPINE FUMARATE 60 <11 <11 A 36 57
TRAZODONE HCL 58 53* 12 38 48
GLIPIZIDE XL 58 <11 <11 38 130
LANTUS 57 <11 <11 40 53
METFORMIN HCL ER 56 51* 13 41 68
CRESTOR 53 <11 <11 42 27
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.